Moberg Pharma AB (publ) (MOB.ST)
SEK 11.28
(10.37%)
SEK 11.28
(10.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | 207 Thousand | - | 33.65 Million | 439.04 Million | 439.03 Million |
| Cost of Revenue | 2.09 Million | 2.58 Million | 2.58 Million | 151.00 | 104.43 Million | 125.17 Million |
| Gross Profit | -2.09 Million | -2.37 Million | -2.58 Million | 33.65 Million | 334.6 Million | 313.85 Million |
| Operating Expenses | 27.46 Million | 20.72 Million | 19.52 Million | 21.68 Million | 279.84 Million | 276.58 Million |
| Selling, General and Administrative Expenses | 24.86 Million | 1.01 Million | 70 Thousand | 179 Thousand | 226.96 Million | 226.57 Million |
| Research and Development Expenses | 2.38 Million | 21.23 Million | 21.88 Million | 24 Million | 58.33 Million | 49.02 Million |
| Other Expenses | -1.05 Million | -1.52 Million | -2.43 Million | -2.49 Million | -5.45 Million | 991 Thousand |
| Cost and Expenses | 27.46 Million | 20.72 Million | 19.52 Million | 21.68 Million | 384.27 Million | 401.76 Million |
| Operating Income | -27.46 Million | -20.51 Million | -19.73 Million | -21.68 Million | 64.81 Million | 51.07 Million |
| Interest Expense | 260 Thousand | 71 Thousand | 129 Thousand | 1.84 Million | 36.31 Million | 39.4 Million |
| Income Tax Expense | -4.32 Million | -3.8 Million | -3.74 Million | -4.47 Million | 6 Million | 515 Thousand |
| Earnings before Tax | -25.42 Million | -19.51 Million | -19.97 Million | -23.5 Million | 25.84 Million | 11.67 Million |
| Net Income | -21.09 Million | -15.71 Million | -16.22 Million | -19.02 Million | 19.83 Million | 11.15 Million |
| Earnings Per Share Basic | -1.33 | -1.38 | -2.43 | -6.51 | 6.39 | 5.47 |
| Earnings Per Share Diluted | -1.33 | -1.38 | -2.37 | -6.47 | 6.39 | 5.43 |
| Weighted Average Shares Outstanding | 15.85 Million | 11.38 Million | 6.68 Million | 2.92 Million | 3.1 Million | 2.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.87 Million | 11.38 Million | 6.85 Million | 2.93 Million | 3.1 Million | 2.05 Million |
| Gross Margin | - | -11.47 | - | 1.00 | 0.76 | 0.71 |
| EBIT Margin | - | -81.44 | - | -0.57 | 0.21 | 0.17 |
| Profit Margin | - | -75.89 | - | -0.57 | 0.05 | 0.03 |
| EBITDA | -26.95 Million | -16.85 Million | -17.14 Million | 12.58 Million | -3.24 Million | 89.44 Million |
| Earnings Before Tax Margin | - | -99.12 | - | -0.64 | 0.15 | 0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.1 Million | 820 Thousand | - | - | - | - |
| Cost of Revenue | 1.38 Million | 328 Thousand | 2.09 Million | 260 Thousand | 613 Thousand | 613 Thousand |
| Gross Profit | 2.72 Million | 492 Thousand | -2.09 Million | -260 Thousand | -613 Thousand | -613 Thousand |
| Operating Expenses | 8.15 Million | 8.38 Million | 26.41 Million | 8.23 Million | 7.26 Million | 5.29 Million |
| Selling, General and Administrative Expenses | 7.88 Million | 8.09 Million | - | 7.19 Million | 6.42 Million | 5.2 Million |
| Research and Development Expenses | 267 Thousand | 921 Thousand | - | 1.03 Million | 693 Thousand | 1.1 Million |
| Other Expenses | 73 Thousand | - | - | - | - | - |
| Cost and Expenses | 9.54 Million | 8.71 Million | 28.51 Million | 8.49 Million | 7.26 Million | 5.29 Million |
| Operating Income | -5.43 Million | -7.89 Million | -28.51 Million | -8.49 Million | -7.26 Million | -5.29 Million |
| Interest Expense | 58 Thousand | 62 Thousand | 260 Thousand | 52 Thousand | 63 Thousand | 72 Thousand |
| Income Tax Expense | -1.32 Million | -1.01 Million | -4.32 Million | -1.04 Million | -1.18 Million | -1 Million |
| Earnings before Tax | -5.37 Million | -7.51 Million | -25.42 Million | -7.48 Million | -6.95 Million | -4.85 Million |
| Net Income | -4.04 Million | -6.49 Million | -21.09 Million | -6.44 Million | -5.76 Million | -3.85 Million |
| Earnings Per Share Basic | -0.13 | -0.23 | - | -0.23 | -0.36 | -0.26 |
| Earnings Per Share Diluted | -0.13 | -0.14 | - | -0.23 | -0.36 | -0.26 |
| Weighted Average Shares Outstanding | 30.04 Million | 27.96 Million | 15.87 Million | 27.96 Million | 15.87 Million | 14.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.04 Million | 47.61 Million | 15.87 Million | 27.96 Million | 15.87 Million | 14.74 Million |
| Gross Margin | 0.66 | 0.60 | - | - | - | - |
| EBIT Margin | -1.32 | -8.69 | - | - | - | - |
| Profit Margin | -0.98 | -7.92 | - | - | - | - |
| EBITDA | -5.43 Million | -7.12 Million | - | -8.23 Million | -6.27 Million | -4.17 Million |
| Earnings Before Tax Margin | -1.32 | -9.63 | - | - | - | - |
SALEM
005725
NXNN
CEVI
300793
TELHF